Highest-materiality recent filing
DNA X raises $2.5M in Series B Preferred, cancels $3.1M debt to meet Nasdaq equity requirement
Sold 929,864 Series B Preferred shares for $2.5M cash and cancellation of $3.1M convertible note balance.
DNA X enters securities purchase agreement for $8.1M private placement of Series B Preferred Stock
DNA X agreed to issue 1,346,531 shares of Series B Convertible Preferred Stock at $6.00 per share to DNA Holdings Venture, Inc. for aggregate $8.1M.
DNA X terminates $500M equity line with Chardan Capital Markets
Terminated ChEF Purchase Agreement with Chardan Capital Markets, effective May 28, 2026.
DNA X receives Nasdaq delisting notice; issues $3.05M convertible note to insider
Nasdaq delisting notice due to stockholders' deficit of $983,000 as of March 31, 2026; hearing requested.
DNA X Q1 2026: asset sale nets $6.3M; no continuing revenue; raises $1.8M debt
Completed sale of mobile device assets to NEXA for $15M (net $13.5M after working capital adj); $12M paid, $1.5M due Oct 2026.
DNA X (SONM) dismisses auditor Baker Tilly, engages TAAD; 2025 audit includes going concern
Audit committee dismissed Baker Tilly on April 27, 2026; engaged TAAD LLP for fiscal 2026.
DNA X reports FY2025 no revenue from continuing ops; closes mobile asset sale for $15M
No revenue from continuing operations in Q4 2025; G&A expenses $1.2M primarily for acquisition and sale costs.
DNA X amends 8-K to de-classify its share-based acquisition as not significant
Company determined that its acquisition of DNA X LLC for 223,201 shares (19.99% stake) is not a 'significant amount of assets' under SEC rules.
DNA X appoints Mike Mulica as acting CEO; salary $450k, 50k RSUs; CFO Crolius gets 35k RSUs
Mike Mulica appointed acting CEO effective Feb 9, 2026; base salary raised to $450,000 retroactive to Jan 30.
CEO Peter Liu and CCO Charles Becher resign; Scott Walker appointed to board
CEO Peter Liu resigned Jan 30, 2026, with $855,000 severance in two tranches ($427,500 each).
Asset sale of enterprise 5G solutions business to Pace Car Acquisition LLC (NEXA) closed Jan 23, 2026; post-closing cash ~$6.2M.
Sonim stockholders approve sale of Legacy Business to Pace Car Acquisition LLC
Stockholders approved Asset Purchase Agreement to sell Legacy Business (enterprise 5G solutions, rugged handsets, smartphones) to Pace Car Acquisition LLC.
Sonim issues $1.2M convertible note, acquires DNA X DeFi protocol for 19.99% stock
Issued $1.2M convertible promissory note to DNA Holdings, 10% interest, due Dec 2026, convertible at $5.50/share.
CFO Clay Crolius gets contingent cash bonus equal to value of $100,000 face amount phantom RSUs vesting on asset purchase closing.
Sonim amends asset purchase agreement, removes reverse merger, adds payment condition
Removed all references to reverse merger (RTO) and related Form S-4 filing from the purchase agreement.
Sonim regains Nasdaq minimum bid price compliance; bid price above $1.00 since Oct 27
Nasdaq Staff confirmed closing bid price at $1.00+ from Oct 27 to Nov 11, 2025.
Net revenue $16.2M, up 45% sequentially from Q2; GAAP net loss $4.8M vs $7.5M in Q2.
Sonim Technologies approves 1-for-18 reverse stock split effective October 27, 2025
Shareholders approved reverse split at Oct 16 special meeting; board set ratio at 1-for-18.
Sonim appoints Executive Chairman, approves 1-for-18 reverse split; Nasdaq extension to Dec 31
Michael Mulica appointed Executive Chairman effective Oct 16, 2025; receives $300k salary, $250k annual RSU grant, and $500k RSU award tied to asset purchase with Social Mobile.
Sonim enters up to $500M equity facility with Chardan Capital Markets
Sonim may sell up to $500M in common stock to Chardan over 36 months at VWAP minus 3.5% discount.
Sonim receives Nasdaq deficiency notice for low stockholders' equity of $1.334M
Nasdaq notified Sonim on Aug 22, 2025 that stockholders' equity of $1.334M as of June 30, 2025 is below the $2.5M minimum for continued listing.
Sonim receives Nasdaq deficiency notice for minimum bid price non-compliance
Nasdaq notified Sonim on Aug 13, 2025, that bid price closed below $1.00 for 30 consecutive business days.
Sonim enters €3M factoring at 15% discount, cuts warrant exercise price to $0.75
Entered factoring agreement with Tradewind GmbH; eligible receivables purchased at 15% discount; max financing €3M.
Sonim Q2 net loss $7.5M, revenue $11.2M; Social Mobile acquisition for $15M
GAAP net loss of $7.5M vs net income $0.5M in Q1; revenue $11.2M down 33% QoQ from $16.7M (incl. $5.3M one-time item).
Compensation committee approved $55,000 special cash award to each special committee member and $35,000 to the chair.
Purchase price $15M cash (subject to working capital adjustments) plus earn-out: 50% of net revenue above $70M in 12 months ending June 30, 2026, capped at $5M.
Sonim issues $2.755M secured note to Streeterville Capital; net proceeds $2.5M
Note carries 9% annual interest, matures 18 months from July 11, 2025; OID of $225K and $30K transaction fees.
Sonim Technologies prices public offering of 7.4M shares at $0.75, raising ~$4.9M net
Offering of 7,400,000 common shares at $0.75 per share closed July 2, 2025.
Sonim Technologies signs LOI for reverse takeover with AI HPC factory valued at ~$300M
Target is private US company building Nvidia-based HPC AI factories; valuation ~$300M supported by fairness opinion.
Sonim Technologies replaces auditor Moss Adams with Baker Tilly after merger
Moss Adams merged into Baker Tilly US, LLP effective June 3, 2025; Baker Tilly appointed as new auditor.
Sonim Technologies raises $1.375M via private placement of stock and warrants
1.1M shares of common stock and warrants for 550K shares sold for $1.375M total.
Sonim Q1 revenue $16.7M (+12% seq), GAAP net income $0.5M; adj EBITDA -$3.2M
Net revenue $16.7M, +12% sequentially; GAAP net income $0.5M vs Q4 2024 loss of $21.6M.
Adopted limited-duration stockholder rights agreement triggered at 15.5% ownership (20% for passive investors), expiring April 21, 2026.
Sonim amends CFO employment agreement, enhancing severance upon change in control
Change in Control definition expanded to include removal of majority of Board over two years or asset sale/liquidation.
Sonim amends CEO severance to 150% salary plus bonus; expands special committee
CEO Peter Liu's employment agreement amended: severance on Change in Control increased to 150% of base salary plus pro-rated target bonus.
Sonim Technologies reports FY2024: Q4 revenue $15M (+12%), full year $58.3M (-38%)
Q4 revenue $15.0M (+12% YoY); full year revenue $58.3M (-38% YoY) due to strategic shift from white-label to own products.
Sonim issues $3.3M promissory note to Streeterville Capital, net proceeds $3M
Note principal $3.3M; $270K OID and $30K transaction costs deducted; net proceeds $3M.
Sonim awards RSUs to 97 employees; CEO Liu receives 63,604 units
CEO Peter Liu awarded 63,604 RSUs; CCO Charles Becher 70,671; CFO Clay Crolius 33,922.
Special Committee comprised of Mike Mulica (chair) and James Cassano, both independent directors.
Sonim Q4 preliminary: $15.2M revenue (+13% YoY), net loss $20-24M (vs $3M Q3), cash $5M
Revenue ~$15.2M, up 13% YoY from $13.4M and up sequentially from $15.0M in Q3.
Sonim Q3 revenue up 30.4% sequentially to $15.0M; net loss narrows to $2.5M
Net revenue $15.0M, up 30.4% from Q2 2024; GAAP net loss $2.5M vs. $6.6M in Q2 including $3.2M impairment.
Sonim enters $2.5M receivables factoring facility with LS DE LLC
Agreement provides advances of 80% of invoice face value up to $2.5M total.
Sonim Q2 revenue $11.5M, net loss $6.6M; expects H2 sequential growth
Net revenues of $11.5M, down from $16.8M in Q1 2024.
Sonim Technologies enters ATM equity offering agreement for up to $8.94M
Company entered Sales Agreement with Roth Capital Partners for ATM offering of common stock up to $8,943,000.
Sonim Technologies regains Nasdaq minimum bid price compliance
Nasdaq notified Sonim on August 2, 2024, that its closing bid price was $1.00 or greater from July 18 to August 1, 2024.
Sonim Technologies completes 1-for-10 reverse stock split effective July 17, 2024
Reverse stock split ratio 1-for-10 approved by board after stockholder authorization at June 20, 2024 annual meeting.
Sonim Technologies announces 1-for-10 reverse stock split to regain Nasdaq compliance
Board approved 1-for-10 reverse stock split; effective 5:00 p.m. ET on July 17, 2024.
Sonim shareholders approve reverse stock split, authorized share increase, and equity plan expansion
Approved reverse stock split at ratio of 1-for-2 to 1-for-15, at Board discretion, within one year.
Sonim Technologies amends bylaws for meeting chair/secretary and technical corrections
Board gains power to designate chairperson and secretary for stockholder meetings.
Sonim Technologies extends registration statement filing deadline to September 20, 2024
Company amended Registration Rights Agreement with investor Jiang Liu on June 2, 2024.
On August 3, 2023, Alan Howe informed the board of directors (the “Board”) of Sonim Technologies, Inc. (the “Company”) of his decision to retire from, and not stand for re-election to the Board, effective as of the end of his term, the date of the conclusion of the Company’s 2023 annual meeting of stockholders.
On August 3, 2023, Jose C. Principe informed the Board of his decision to retire from, and not stand for re-election to the Board, effective as of the end of his term, the date of the conclusion of the Company’s 2023 annual meeting of stockholders.
On August 20, 2022, Sonim Technologies, Inc., a Delaware corporation (the “ Company ”), entered into an employment agreement (the “ Employment Agreement ”) with Peter Hao Liu in connection with his role as Chief Executive Officer (“ CEO ”) of the Company.
On July 14, 2022, the board of directors (the “Board”) of Sonim Technologies, Inc., a Delaware corporation (the “Company”) elected Messrs. Peter Hao Liu and Jose Carlos Principe, Ph.D., to serve as members of the Board, effective July 14, 2022.
On July 14, 2022, the board of directors (the “Board”) of Sonim Technologies, Inc., a Delaware corporation (the “Company”) elected Messrs. Peter Hao Liu and Jose Carlos Principe, Ph.D., to serve as members of the Board, effective July 14, 2022.
On July 13, 2022, Robert Tirva, President, Chief Financial Officer and Chief Operating Officer (principal financial and accounting officer) of the Company resigned from his positions with the Company and its affiliates.
the Board appointed Clay Crolius as Chief Financial Officer (principal financial and accounting officer) of the Company.
John Kneuer and Sue Swenson resigned from the Board and each respective committee of the Board to which they were appointed.
Jeffrey Wang, Director, Chairman of the Board
John Kneuer and Sue Swenson resigned from the Board and each respective committee of the Board to which they were appointed.
On April 13, 2022, the Compensation Committee of the Board of Directors of the Company approved a letter agreement with Robert Tirva, the Company’s President, Chief Financial Officer and Chief Operating Officer. The agreement provides that Mr. Tirva’s employment with the Company will terminate on, and subject to, the First Closing and that upon such termination, Mr. Tirva would be entitled to receive
on April 13, 2022, the board of directors of Sonim appointed Peter Liu as Chief Executive Officer of the Company
Max materiality 0.90 · Median 0.62 · Most common event other_material